Sanara MedTech (SMTI) Shares Outstanding (Weighted Average) (2016 - 2025)
Sanara MedTech's Shares Outstanding (Weighted Average) history spans 15 years, with the latest figure at $8.6 million for Q4 2025.
- For Q4 2025, Shares Outstanding (Weighted Average) rose 1.64% year-over-year to $8.6 million; the TTM value through Dec 2025 reached $8.6 million, up 1.64%, while the annual FY2025 figure was $8.6 million, 1.64% up from the prior year.
- Shares Outstanding (Weighted Average) reached $8.6 million in Q4 2025 per SMTI's latest filing, roughly flat from $8.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $8.6 million in Q3 2025 to a low of $6.8 million in Q1 2021.
- Average Shares Outstanding (Weighted Average) over 5 years is $8.1 million, with a median of $8.2 million recorded in 2023.
- Peak YoY movement for Shares Outstanding (Weighted Average): surged 43.45% in 2021, then increased 1.64% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.3 million in 2021, then grew by 7.7% to $7.9 million in 2022, then rose by 4.71% to $8.3 million in 2023, then grew by 2.48% to $8.5 million in 2024, then rose by 1.64% to $8.6 million in 2025.
- Per Business Quant, the three most recent readings for SMTI's Shares Outstanding (Weighted Average) are $8.6 million (Q4 2025), $8.6 million (Q3 2025), and $8.6 million (Q2 2025).